# FDA Inspection 1225621 - Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd. - December 08, 2023

Source: https://www.keypedia.com/records/fda_inspections/guangzhou-baiyunshan-jingxiutang-pharmaceutical-co-ltd/8a97e40c-ff49-4130-82f7-8b8896783e70
Source feed: FDA_Inspections

> FDA Inspection 1225621 for Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd. on December 08, 2023. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225621
- Company Name: Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.
- Inspection Date: 2023-12-08
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1011944 - 2017-05-12](https://www.keypedia.com/records/fda_inspections/guangzhou-baiyunshan-jingxiutang-pharmaceutical-co-ltd/11136792-82be-447f-8a95-4dac4d601c33)

Company: https://www.keypedia.com/companies/guangzhou-baiyunshan-jingxiutang-pharmaceutical-co-ltd/895bc692-0c4b-4fa9-89be-179cb75655bc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c